- Poster presentation
- Open Access
Impact of antibiotic utilization measures on acquisition rate of extended spectrum β-lactamase enzymes producing bacteria
Critical Care volume 11, Article number: P106 (2007)
Antibiotic resistance patterns are continually changing; a new problem has been the emergence of Gram-negative bacteria, primarily Escherichia coli and Klebsiellae pneumoniae, producing extended spectrum β-lactamase enzymes (ESBL). Antibiotic use measures are presumably the most important intervention in preventing their clonal outbreak, and the risk factors for ESBL include intensive antibiotic exposure (especially third-generation cephalosporin monotherapy). The present study was performed to determine the impact of using piperacillin/tazobactum in reducing the acquisition rate of ESBL producing Gram-negative bacteria in the ICU.
This open-label, prospective study was carried out in 140 adult patients admitted to the ICU over a period of 9 months, and was divided into two phases. Phase I (pre-intervention phase, 0–3 months): upon admission to the ICU, besides standard investigations, additional rectal swab cultures were taken for detection of ESBL within and after 48 hours of admission, and were repeated every 7 days of the stay in the ICU. Routinely prescribed antibiotics were allowed. Phase II (intervention phase, 4–9 months): this was subdivided into (a) first 3 months (4–6 months): piperacillin/tazobactum was the primary antibiotic used (more than 50% replacement of cephalosporins), and (b) last 3 months (7–9 months): here again, rectal swab cultures were taken and piperacillin/tazobactum was the primary antibiotic used. McNemar's test and Fisher's exact test were used for statistical analysis.
Eighty-five patients in phase I and 55 patients in phase II were enrolled. Third-generation cephalosporins were the primary antibiotic in 75.2% of cases in phase I and in 1.8% of cases in phase II (P < 0.001). The incidence of ESBL was 62.3% in phase I and it came down to 34.5% in intervention phase II (P < 0.01).
Data from this intervention study support the concept that third-generation cephalosporins are of substantial importance in the emergence of ESBL; by decreasing the level of third-generation cephalosporin use and increasing the piperacillin/tazobactum use, their was a notable reduction in the acquisition rate of ESBL producing E. coli.
About this article
Cite this article
Gurnani, A., Jain, A., Sengupta, S. et al. Impact of antibiotic utilization measures on acquisition rate of extended spectrum β-lactamase enzymes producing bacteria. Crit Care 11, P106 (2007). https://0-doi-org.brum.beds.ac.uk/10.1186/cc5266
- Intervention Phase
- Resistance Pattern
- Acquisition Rate
- Utilization Measure